Endocare provides cryotherapy technology to urologists for the treatment of prostate and renal cancer. This is a minimally invasive option that leads to fast recovery and offers hope for patients who have failed to respond to pharmacological treatments, and for others who want to avoid gland removal. CEO Davenport was interviewed in October 2006 at the C.E. Unterberg Investment Conference.